Monday, November 18, 2024
- 10:30AM-12:30PM
-
Abstract Number: 2106
EP-104IAR (Long-Acting Intra-Articular Injection of Fluticasone Propionate) Shows Sustained Improvement in Pain for Subjects with Moderate Baseline Pain and BMI Less Than 30 in SPRINGBOARD, a Phase 2, Randomized, 24-Week Study of Osteoarthritis of the Knee
Osteoarthritis – Clinical Poster II- 10:30AM-12:30PM
-
Abstract Number: 2123
Epidemiology of Bone Health and Fracture in Gout Patients
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster- 10:30AM-12:30PM
-
Abstract Number: 2434
ESK-001, an Allosteric TYK2 Inhibitor, Maximally Suppresses Type 1 Interferon, a Therapeutic Pathway Central to SLE and CLE
SLE – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 1927
Ethnic and Racial Minorities in Clinical Trials for Autoimmune Connective Tissue Disease Therapeutic Agents
Healthcare Disparities in Rheumatology Poster III- 10:30AM-12:30PM
-
Abstract Number: 1938
Evaluating Diagnostic Performance of Mycobacterium Tuberculosis Derived Cell-free DNA (CF-DNA) for Diagnosis of Osteoarticular Tuberculosis (OATB): A Novel Method
Health Services Research – ACR/ARP Poster III- 10:30AM-12:30PM
-
Abstract Number: 2178
Evaluating the Non-Inferiority of Mycophenolate Mofetil Compared to Methotrexate in Treating Juvenile Localized Scleroderma
Pediatric Rheumatology – Clinical Poster III- 10:30AM-12:30PM
-
Abstract Number: 2179
Evaluation of Diagnostic Concordance Between Telehealth Encounters and In-Person Follow-up Assessments in Pediatric Rheumatology
Pediatric Rheumatology – Clinical Poster III- 10:30AM-12:30PM
-
Abstract Number: 2043
Evaluation of Medication Adherence of FMF Patients Transitioned from a Pediatric Clinic to an Adult Clinic: A Cross-sectional Study
Miscellaneous Rheumatic & Inflammatory Diseases Poster III- 10:30AM-12:30PM
-
Abstract Number: 1904
Evaluation of the Economic Burden of Psoriatic Arthritis: Assessment of Direct Costs Using National Administrative Databases at National Level
Epidemiology & Public Health Poster III- 10:30AM-12:30PM
-
Abstract Number: 2120
EvaluationofBone Mineral Densityand Trabecular Bone Score in JuvenileSystemicLupusErythematosusPatientsUsing Dual-Energy X-rayAbsorptiometry
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster- 10:30AM-12:30PM
-
Abstract Number: 2272
Evolution of Methotrexate and Prednisone Use in the Era of Biologic Therapy: 15-Year Findings from a Large Rheumatoid Arthritis Registry
RA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 2202
Evolving Phenotypic and Genotypic Spectrum of Human ISG15 and USP18 Deficiencies
Pediatric Rheumatology – Clinical Poster III- 10:30AM-12:30PM
-
Abstract Number: 1954
Examination of Rehabilitation Referrals from Rheumatology Practices for Adults with Rheumatoid Arthritis in the RISE Registry: A Feasibility and Descriptive Study
Health Services Research – ACR/ARP Poster III- 10:30AM-12:30PM
-
Abstract Number: 1850
Exhausted T-cells Are Increased in Autoimmune Diseases and Predict Response to Anti-TNF in RA and SPA Patients